Avedro gets a VC on board
This article was originally published in Clinica
As Avedro awaits US FDA approval of its drug-device product for treating complications from refractive surgery, the Massachusetts firm has appointed David McIntyre, a venture capitalist, to its board of directors. David McIntyre currently serves as partner for Apple Tree Partners, a healthcare venture capital firm, where he oversees operations of fund finances and medical device investments. Mr McIntyre’s medtech industry experience also includes serving as executive vice-president, chief financial officer and chief operating officer for heart assist device maker HeartWare International.